Vitamin D in Bone and Kidney graft Health Post renal Transplant

Study of Therapeutic Role Of Vitamin D in Bone mineral Density and renal allograft survival. - TRuVitaD

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065874

Enrollment

Registered

2024-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z940- Kidney transplant status

Interventions

Intervention1: Standard dose 25 (OH)Vitamin D: Standard dose of Vitamin D in Vitamin D deficient post transplant patients Control Intervention1: 25 (OH) Vitamin D in low dose i.e 3000 IU/week then 1/m

Eligibility

Inclusion criteria

Inclusion criteria: 1) Renal Transplant Recipients with Vitamin D deficiency 2) Age more than 18 years 3) Patients who understand risks and benefits of enrolling into the study

Exclusion criteria

Exclusion criteria: 1. Hypercalcemia ( > 9 mg/dl) 2. Hyperphosphetemia ( >15 mmol/l) 3. Vitamin D Hypersensitivity 4. Hypervitaminosis D (Vitamin D levels > 80 ng/ ml) 5. Adynamic Bone Disease (serum iPTH levelsÂ 6. Havenâ??t provided written consent

Design outcomes

Primary

Measure	Time frame
1) graft failure 2) deathTimepoint: 0,3,6,12 months	—

Secondary

Measure	Time frame
1)rejection 2)infections Timepoint: 0,3,6,12 months	—

Countries

India

Contacts

Public ContactDR Harsh Patel

Muljibhai Patel Urological Hospital

abhijit@mpuh.org9825316112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026